Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 351 - 400 out of 73,787

Document Document Title
WO/2017/018863A1
The present invention relates to a hexuronate C4-epimerase mutant having improved conversion activity of hexuronate C4-epimerase, and a method for producing tagatose using the same.  
WO/2017/019448A1
Methods for improving the ability of a population of biological agents to compete and survive in a field setting are provided. The improved, modified population of agents is able to grow, compete with other microbial strains and fungi, a...  
WO/2017/017662A4
Invention concerns a microorganism strain Lactobacillus Plantarum LS/07 CCM 7766 and a method of its use for the purposes of adjustment and stabilization of healthy intestinal microflora of a man. Microorganism strain Lactobacillus Plant...  
WO/2017/016175A1
Disclosed is a hydroxyl protection reaction method of aesculin based on Pseudomonas stutzeri cell catalysis, involving the following : an organic solvent, an aesculin hydrate, an acylation substrate and a Pseudomonas stutzeri cell cataly...  
WO/2017/015529A1
Embodiments of the invention provide fluidic devices such as, but not limited to, microfluidic chips, with one or more freeze thaw valves (FTVs) employing one or more ice-nucleating agents (INAs), that can reliably operate to freeze at r...  
WO/2017/012571A1
Provided is a use of a Bacillus coagulans strain in increasing egg production in a laying hen. The Bacillus coagulans is combined with a Bacillus subtilis (CCTCC No. M2011443) and a Bacillus licheniformis (CCTCC No. M2012458) to obtain a...  
WO/2017/015208A1
The present invention provides a wound dressing and method for treating wounds that introduces and/or promotes the growth of non-pathogenic bacteria or single-celled eukaryotes such as fungi, yeast, or algae over pathogenic bacteria or s...  
WO/2017/012570A1
Provided is a Bacillus coagulans strain (serial number: ZS-007) deposited in the China Center for Type Culture Collection (CCTCC) and having a deposition number of CCTCC M2015273. Also provided are a fermentation method of the Bacillus c...  
WO/2017/012573A1
Provided is a Bacillus pumilus strain (serial number: ZS008) deposited in the China Center for Type Culture Collection (CCTCC) on July 13, 2015 and having a deposition number of CCTCC No. M2015451. Also provided is a microbial ecological...  
WO/2017/012569A1
Provided is a Bacillus combined water-purifying agent for a pet fish, comprising the following species: a Bacillus subtilis (CCTCC No. M2011443), a Bacillus licheniformis (CCTCC No. M2012457), a Bacillus coagulans (CCTCC No. M2015273), a...  
WO2017011565A1
Provided herein are compositions and methods for diagnosing and characterizing tuberculosis infection. In particular, provided herein are compositions and methods for identifying drug resistant tuberculosis.  
WO2017008482A1
Provided is a Rhodotorula sp. strain, OMK-1, having a deposition number of CCTCC M 2015326. Further provided is a production method of natural cinnamic acid using fermentation of the Rhodotorula sp. strain, OMK-1, the production method c...  
WO2017008638A1
Provided is a recombinant P particle formed from a norovirus capsid P protein of a chimeric A beta 1-m peptide (m being an integer between 6 and 15), wherein the recombinant P particles form an ordered and repetitive antigen array. Also ...  
WO/2017/006918A1
[Problem] To provide a Labyrinthulid microorganism capable of producing a PUFA only through the elongase-desaturase pathway. [Solution] A Labyrinthulid microorganism which does not have an ability of producing a PUFA through the endogeno...  
WO/2017/005584A1
The present invention refers to a new strain belonging to the species Lactobacillus paracasei able to convert linoleic acid into conjugated linoleic acid. The present invention refers also to nutritional or food preparations and/or pharm...  
WO/2017/005213A1
A preparation method of recombining and expressing lysine-specific endoprotease in Pichia pastoris. The method comprises: optimizing, according to a codon preference of a yeast, a gene sequence of a lysine-specific endoprotease; construc...  
WO/2017/005584A9
The present invention refers to a new strain belonging to the species Lactobacillus paracasei able to convert linoleic acid into conjugated linoleic acid. The present invention refers also to nutritional or food preparations and/or pharm...  
WO/2017/008018A1
Provided herein are microorganisms engineered with heme-responsive transcription factors and genetic circuits. Also provided are methods for using engineered microorganisms to sense bleeding events and treat bleeding in vivo.  
WO/2017/005048A1
The present invention provides a monoclonal antibody that specifically binds to human procalcitonin and application thereof. The present invention also provides a hybridoma cell line secreting the monoclonal antibody and having an access...  
WO/2017/000366A1
Provided in the present invention is a method for preparing rebaudioside M by using an enzymatic process, which catalyzes the formation of rebaudioside M using a recombinant Saccharomyces cerevisiae containing a UDP-glucosyltransferase o...  
WO/2017/001678A1
The invention relates to a new bicyclic lipolantipeptide, representing a new class of lantipeptide, and salts thereof, their preparation from a culture of a Microbacterium arborescens, and their use as antimicrobial agent in the preventi...  
WO/2017/001677A1
The present invention relates to the use of a bacterium of the genus Microbacterium for the production of a compound endowed with antibacterial activity.  
WO/2017/000870A1
Provided are a humanized lactate dehydrogenase (LDH) Saccharomyces cerevisiae and the construction method thereof. In particular, the method of gene homologous recombination is used to knockout the genes PDC1, PDC5 and PDC6 which encode ...  
WO/2017/003103A1
The present invention relates to novel separated Pseudomonas stutzeri, which enables deamidation of an amino compound, and a method, for deamidating an amino compound, using same.  
WO/2016/208699A1
[Problem] To provide a method for the industrial production of an optically active fluoroalkyl ethylene oxide. [Solution] An optically active fluoroalkyl chloromethyl alcohol having a high optical purity can be produced at a high yield b...  
WO/2016/208542A1
The present invention addresses the problem of developing and providing a method for producing a polyhydroxyalkanoic acid (PHA) at reduced cost, with high efficiency and in a large quantity using a microorganism. Provided is a method for...  
WO/2016/210097A1
The invention is directed to isolated equine parvovirus (EqPV), and isolated nucleic acids sequences and polypeptides thereof. The invention also relates to antibodies against antigens from EqPV. The invention also relates to iRNAs which...  
WO/2016/210373A3
The present disclosure provides methods for treating a disease or disorder by administering a programmed recombinant bacterial cell to a subject, wherein the programmed recombinant bacterial cell expresses a heterologous gene in response...  
WO/2016/209117A1
The invention relates to microbiology, and more particularly to nutrient media used for cultivating bacteria for the subsequent study thereof. A nutrient medium comprising a pancreatic digest of casein, a peptic digest of meat, a heart p...  
WO/2016/207744A1
The present disclosure provides a culture medium capable of being used for clonal growth of Streptococcus pneumoniae to produce capsular pneumococcal polysaccharide for vaccine production, wherein the culture medium can include KH2PO4, N...  
WO/2016/209612A1
A process for the creation of ethanol from cellulosic materials using the bacteria Cellulomonas sp. and aerobic Zymomonas mobilis in the same medium under the same conditions to breakdown cellulosic materials into glucose and to ferment ...  
WO/2016/210373A2
The present disclosure provides methods for treating a disease or disorder by administering a programmed recombinant bacterial cell to a subject, wherein the programmed recombinant bacterial cell expresses a heterologous gene in response...  
WO/2016/207403A1
The present invention relates to a recombinant Deinococcus bacterium comprising a heterologous biosynthetic pathway converting 3-dehydroshikimate to catechol and/or cis,cis-muconic acid and its use for producing cis,cis-muconic acid or c...  
WO/2016/208861A1
The present invention relates to a Streptomyces badius SP6C4 strain isolated from strawberry pollen and having an antibacterial activity against insect pathogens, and a use thereof. In the present invention, it was verified that the Stre...  
WO/2016/201536A1
The present invention relates to a biotransformation method for transforming phenolic compounds from soy milk into bioactive isoflavones and equol, with a high yield and production volume, for use in the biotechnological field, mainly in...  
WO/2016/204500A1
The present invention relates to a method for collecting and detecting bacteria and viruses simultaneously by means of an impaction technique, and the purpose thereof is to provide a method for collecting and detecting bacteria and virus...  
WO/2016/204689A1
There is provided a method for recovering spent grain, comprising the steps of: a) adding a batch of mixed solution of a batch of spent grain and a first fermenting composition to a second fermenting composition; b) mixing the added batc...  
WO/2016/200614A3
Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of modulating and treating disorders associated with hyperammonemia are disclosed.  
WO/2016/197561A1
Provided are a methionine lyase and an encoding gene thereof, wherein the gene is isolated from Tuber melanosporum and the nucleotide sequence thereof is as shown in SEQ ID No. 1. Further provided is a method for efficiently biosynthesiz...  
WO/2016/198852A1
The invention relates to a genetically transformed or transfected bacterial cell of a gut symbiont of an insect belonging to the Order Thysanoptera wherein said cell is transformed to express double-stranded RNA (dsRNA) active against at...  
WO/2016/200614A2
Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of modulating and treating disorders associated with hyperammonemia are disclosed.  
WO/2016/191828A1
The present invention relates to microbial inoculants, fertiliser compositions, growth mediums and methods for enhancing plant growth. In one aspect, the invention relates to a method of increasing plant growth, plant productivity, seed ...  
WO/2016/192871A1
The invention relates to mutant bacteria of the genus Clostridium beijerinckii, CNCM I-4985, CNCM I-4986, CNCM I-4987 and CNCM I-4988, deposited on the 27th May 2015 at the Pasteur institute (CNCM, 25 rue du Docteur Roux, F-75724 PARIS C...  
WO/2016/193896A1
The present invention provides for identifying and detecting clinically and economically important Brucella species and their biovars. More specifically the invention provides for novel primers for identifying and detecting clinically an...  
WO/2016/191839A1
The present invention relates to a method for obtaining outer membrane vesicles (OMV) by biofermentation from the Haemophilus aegyptius 254 (Hae254) line, thus obtained outer membrane vesicles (OMV-Hae254), and use thereof to facilitate ...  
WO/2016/196654A1
Transgenic plant species engineered to inhibit aflatoxin production in Aspergillus species, methods of producing such transgenic plant species that can inhibit aflatoxin production, and compositions for such transgenic plant production. ...  
WO/2016/189067A1
The present invention relates to an attenuated Piscirickettsia salmonis bacterium. The bacterium comprises mutations in the amino acid sequence of each of the rpoD, FecR, ATP-grasp domain protein, and FtsH gene products. The invention al...  
WO/2016/190513A1
The present invention relates to a novel indigenous natural lactobacillus, Lactobacillus brevis SPC-SNU 70-2 (KCTC 12777BP), isolated from traditional Korean malt.  
WO/2016/190512A1
The present invention relates to a novel indigenous natural lactobacillus, Lactobacillus curvatus SPC-SNU 70-3 (KCTC 12778BP), isolated from traditional Korean malt.  
WO/2016/187908A1
The present invention provides a novel recombinant oncolytic adenovirus and an application thereof. The recombinant oncolytic adenovirus has dual specificity; namely, tumor-specific replication and tumor-specific killing, can replicate i...  

Matches 351 - 400 out of 73,787